Utility of Optical Genome Mapping in Repeat Disorders

Area of Science:

• Genomics
• Molecular Diagnostics
• Genetic Disorders

Background:

• Repeat sequences in the genome can expand or contract, leading to over 60 Mendelian disorders.
• Current methods for detecting tandem repeat variations are often region-specific and require specialized tools.
• Optical Genome Mapping (OGM) offers a potential alternative for analyzing these complex genomic regions.

Purpose of the Study:

• To investigate the utility of Optical Genome Mapping (OGM) as a diagnostic tool for repeat expansion and contraction disorders.
• To evaluate OGM's effectiveness in a clinical setting with patients prediagnosed with repeat disorders.

Main Methods:

• Optical Genome Mapping (OGM) was performed on 19 patients with a prediagnosis of repeat disorders.
• Results obtained from OGM were confirmed using established fragment analysis techniques.
• Specific repeat expansion/contraction disorders analyzed include Facioscapulohumeral Muscular Dystrophy (FSHD), Friedreich's Ataxia (FA), Fragile X Syndrome (FXS), and Progressive Myoclonic Epilepsy 1A (EPM1A).

Main Results:

• OGM successfully identified the molecular etiology for 9 out of 19 evaluated patients.
• The study confirmed diagnoses for multiple patients with FSHD, FA, FXS, and EPM1A using OGM.
• OGM demonstrated high accuracy when compared against standard fragment analysis methods.

Conclusions:

• Optical Genome Mapping is a valuable diagnostic tool for identifying repeat expansion and contraction diseases.
• OGM provides a comprehensive approach for diagnosing a range of genetic disorders caused by repeat variations.
• This study supports the clinical application of OGM for diagnosing conditions such as FA, FXS, EPM1A, and FSHD.